SecBot SecBot

HCWB

HCW Biologics Inc.
Nasdaq· Pharmaceutical Preparations· Inc. DE· CIK 0001828673 Biotech & Drug Discovery
$1.15 −0.02 (−1.72%)
Oct 26 4:00 PM ET · prev $1.17
Market cap
$2.5M
Nano cap
Median target
$48.00
+4074% · range $48.00–48.00
1 year
−95.0%
from $23.10 · Oct 27
30 days
−36.8%
from $1.82
52-week range
$1.12–23.46
−95% from high · low Oct 22
Avg volume 20D
162.5K
Oct 13 spike 2.13M
Short interest
60.9K
≈2.7% of shares · +557.1%
Days to cover
1.0
at average volume
Insider net
+$530.0K
4 buyers · 0 sellers · 12 mo
New fund stakes
0
Q1 2026 13F · 0 exits
Filing reports
24
analyzed by SecBot
SecBot read BEARISH 10 reports · 90 days
Balance 9 bearish · 0 bullish · 1 neutral oldest → newest, height = score
Avg score ·High conf. 8/10
Strongest BEARISH The SEC declared effective HCW Biologics' S-1 registration statement (File No. 333-299271) on October 9…
All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

Signal stack

Where each data set points today.

  • InsidersBULLISH

    4 insiders bought $530.0K. No open-market sales.

  • InstitutionsMIXED

    Q1 2026: 1 added (0 new), 0 trimmed or exited.

  • EstimatesFALLING

    Current-quarter EPS estimate −$1.080 → −$8.100 over 90 days. 0 up, 1 down in 30 days.

  • Short sellersBUILDING

    Short interest +557.1% to 60.9K shares. 1.0 days to cover, ≈2.7% of shares.

  • TrendDOWNTREND

    43% below its 50-day average. New closing low $1.12 on Oct 22.

Who's buying

13F· Q1 2026
0
new positions
0
exits
FundMoveSharesValue
CITIGROUP INCDOUBLED10,528$3.8K
WELLS FARGO & COMPANY/MNTRIM1,000$971.00
CITIGROUP INCNEAR_EXIT1$1.00
BANK OF AMERICA CORP /DE/ADD210$59.00
BANK OF AMERICA CORP /DE/TRIM146$65.00
HRT FINANCIAL LPTRIM46,497$25.0K
BANK OF AMERICA CORP /DE/DOUBLED339$183.00

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

last action May 2026
12-month targets · 1 analysts

Price is below the lowest target. Median implies +4074%.Targets as of Oct 26, 2026.

Recent actions
DateFirmActionRating
May 28, 2026Maxim Group
MAINTAIN
MAINTAINBuy
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent
Sep 24, 2026
Trading halt
Halt Resumed: HCWB — trading resumed after LUDP (Volatility Trading Pause)
Halted 2026-09-24T14:29:38.000Z | Resumed 2026-09-24T14:34:38.000Z
Sep 24, 2026
Trading halt
Trading Halt: HCWB — LUDP (Volatility Trading Pause)
HCW Biologics Inc. Cm | Market: NASDAQ | Code: LUDP — Volatility Trading Pause
Sep 24, 2026
Trading halt
Halt Resumed: HCWB — trading resumed after LUDP (Volatility Trading Pause)
Halted 2026-09-24T14:04:05.000Z | Resumed 2026-09-24T14:29:01.000Z
Sep 24, 2026
Trading halt
Trading Halt: HCWB — LUDP (Volatility Trading Pause)
HCW Biologics Inc. Cm | Market: NASDAQ | Code: LUDP — Volatility Trading Pause
Sep 18, 2026
Reg SHO list
Reg SHO Threshold: HCWB exited the threshold list
HCW BIOLOGICS INC COM PAR $0.0 | On list since 2026-09-01

Insider ledger

Form 4
$530.0K
bought · 4 insiders
$0
sold · 0 insiders
DateInsiderTypeValue
Jul 29, 2026
GARRETT SCOTT T
Director
BUY$20.0K
Jul 29, 2026
Flowers Lee
SVP of Business Development
BUY$20.0K
Jul 29, 2026
Wong Hing C
Chief Executive Officer
BUY$60.0K
May 22, 2026
Byam Rebecca
Chief Financial Officer
BUY$20.0K
May 22, 2026
Byam Rebecca
Chief Financial Officer
BUY14,235 sh
May 22, 2026
GARRETT SCOTT T
Director
BUY$250.0K
May 22, 2026
GARRETT SCOTT T
Director
BUY177,936 sh
May 22, 2026
Wong Hing C
Chief Executive Officer
BUY$160.0K

Earnings setup

Estimates
−$8.10
EPS estimate, this quarter
−650%
estimate change, 90 days
0↑ 1↓
revisions, 30 days
Current-quarter EPS estimate
PeriodEPS est.Range30D rev.Revenue
Current Q-$8.10-$8.10–-$8.10-650.0%$0.00
Next Q-$8.34-$8.34–-$8.34-672.2%$0.00
Current FY-$28.32-$28.32–-$28.32-883.3%$6.7M
Next FY-$6.30-$6.30–-$6.30-138.6%$0.00

Short side

FINRA· Sep 30, 2026
60,941
shares short
+557.1%
vs prior settlement
1.0
days to cover
≈2.7%
of shares outstanding
Trading halts
Sep 24, 2026Volatility PauseResumed
Sep 24, 2026Volatility PauseResumed
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 13, 2026 SEC
The SEC declared effective HCW Biologics' S-1 registration statement (File No. 333-299271) on October 9, 2026…
EFFECT — Impact 6/10
Oct 2, 2026 SEC
HCW Biologics filed an S-1 registration statement to register the resale of up to 1,807,228 shares of common stock by…
S-1 — Impact 5/10
Oct 1, 2026 SEC
HCW Biologics is holding a special meeting on November 17, 2026 to seek stockholder approval for the issuance of up to…
DEF 14A — Impact 5/10
Sep 24, 2026 Trading halt
Halt Resumed: HCWB — trading resumed after LUDP (Volatility Trading Pause)
Halted 2026-09-24T14:29:38.000Z | Resumed 2026-09-24T14:34:38.000Z
Jul 29, 2026 Press
HCW Biologics priced a $1.6M private placement offering involving insider participation (CEO, Chairman, SVP), issuing…
Impact 6/10
Jul 29, 2026 Insider
GARRETT SCOTT T bought 7,736 shares
Director @ $2.59 ($20.0K)
Jul 29, 2026 Insider
Flowers Lee bought 7,736 shares
SVP of Business Development @ $2.59 ($20.0K)
Jul 29, 2026 Insider
Wong Hing C bought 23,210 shares
Chief Executive Officer @ $2.59 ($60.0K)

SecBot reports

24 filings · 4 press releases · 3 bullish · 13 bearish · 1 mixed · 7 neutral
All HCWB filing & press-release reports (28)